This is Saul Lieberman's Typepad Profile.
Join Typepad and start following Saul Lieberman's activity
Join Now!
Already a member? Sign In
Saul Lieberman
Recent Activity
It seems likely that genome testing is not the extreme frontier of personalized medicine. Someday we might be able to combine knowledge about the genome together with other personal data to go beyond “what might be relevant” to a level of even greater certainty. And I suppose that there may be other data with even greater predictive value than the genome. For example, we might be able to take a sample of cancerous tissue and measure its response to particular chemotherapies before treating the patient. (I am aware of a startup working on exactly that.)
1 reply
Saul Lieberman is now following The Typepad Team
Feb 10, 2011